HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zayra V Garavito-Aguilar Selected Research

Heterologous Transplantation (Xenotransplantation)

1/2019Pilot Study of an Integrative New Tool for Studying Clinical Outcome Discrimination in Acute Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zayra V Garavito-Aguilar Research Topics

Disease

3Neuroblastoma
03/2009 - 06/2004
1Cardiotoxicity
01/2021
1Neoplasms (Cancer)
01/2019
1Leukemia
01/2019

Drug/Important Bio-Agent (IBA)

2Carbachol (Carbastat)FDA Link
10/2004 - 06/2004
12- (4- chloro- 2,5- dimethoxyphenyl)- N- ((2- methoxyphenyl)methyl)ethanamineIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2019
1Lidocaine (Xylocaine)FDA LinkGeneric
03/2009
1Mepivacaine (Carbocaine)FDA LinkGeneric
03/2009
1chloroprocaine (Nesacaine)FDA LinkGeneric
03/2009
1Procaine (Novocaine)FDA LinkGeneric
03/2009
1calcein AMIBA
03/2009
1Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric
03/2009
1ethidium homodimerIBA
03/2009
1Indicators and Reagents (Reagents)IBA
03/2009
1Ropivacaine (Naropin)FDA LinkGeneric
03/2009
1IsofluraneFDA LinkGeneric
10/2004
1Caffeine (No Doz)FDA LinkGeneric
06/2004
1ThapsigarginIBA
06/2004

Therapy/Procedure

1Heterologous Transplantation (Xenotransplantation)
01/2019